Faculty of 1000 evaluation for Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.

Niki Karavitaki, Georgia Ntali
  • November 2015, Faculty of 1000, Ltd.
  • DOI: 10.3410/f.718246432.793511697

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.3410/f.718246432.793511697

The following have contributed to this page: GEORGIA NTALI

In partnership with:

Contributors